NCT00563212View on ClinicalTrials.gov

A Pilot Study of Aerosol Interferon-gamma for Treatment of Idiopathic Pulmonary Fibrosis

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

June 1, 2010

Study Completion Date

December 1, 2018

Conditions
Pulmonary Fibrosis
Interventions
DRUG

aerosol interferon-gamma

aerosol interferon-gamma-1b 100mcg given via nebulizer three times weekly for one year

Trial Locations (1)

10016

Division of Pulmonary & Critical Care Medicine, NYU School of Medicine, New York

Sponsors

Collaborators (1)

Philips Respironics
All Listed Sponsors
collaborator

National Center for Research Resources (NCRR)

NIH

collaborator

Stony Brook University

OTHER

collaborator

Philips Respironics

INDUSTRY

lead

NYU Langone Health

OTHER

NCT00563212 - A Pilot Study of Aerosol Interferon-gamma for Treatment of Idiopathic Pulmonary Fibrosis | Biotech Hunter | Biotech Hunter